Question 1

What is the catalog number for Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued?

Accepted Answer

The catalog number for Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued is V2100-25K-AP.

Question 2

What sizes are available for Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued?

Accepted Answer

Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued is available in the following size(s): 100 µL.

Question 3

Is Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued in stock?

Accepted Answer

Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Varicella-Zoster Virus (VZV), gpI and IV (AP) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-AREB6/ZEB1 Antibody Picoband®, Dylight594 Conjugate

BMI1 (Oncogene and Stem Cell Marker) (BMI1/2689), CF594 conjugate, 0.1mg/mL

Human recombinant GM2A protein, AF

SUMO-1 (SUMO1/1188), CF640R conjugate, 0.1mg/mL

CD137 / 4-1BB / TNFRSF9 (4-1BB/3201), CF568 conjugate, 0.1mg/mL

Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker), 1mg/mL